Abstract:Spinal cord injury (SCI) usually results in loss or reduction in motor and sensory functions. Despite extensive research, no available therapy can restore the lost functions after SCI. Reactive astrocytes play a pivotal role in SCI. Rho kinase inhibitors have also been shown to promote functional recovery of SCI. However, the role of Rho kinase inhibitors in reactive astrocytic phenotype switch within SCI remains largely unexplored. In this study, astrocytes were treated with proinflammatory cytokines and/or the Rho kinase inhibitor Y27632. Concomitantly the phenotype and morphology of astrocytes were examined. Meanwhile, the SCI model of SD rats was established, and nerve functions were evaluated following treatment with Y27632. Subsequently, the number of A1 astrocytes in the injured area was observed and analyzed. Eventually, the expression levels of nuclear factor kappa B (NF-κB), C3, and S100A10 were measured. The present study showed that the Rho kinase inhibitor Y27632 improved functional recovery of SCI and elevated the proliferation and migration abilities of the astrocytes. In addition, Y27632 treatment initiated the switch of astrocytes morphology from a flattened shape to a process-bearing shape and transformed the reactive astrocytes A1 phenotype to an A2 phenotype. More importantly, further investigation suggested that Y27632 was actively involved in promoting the functional recovery of SCI in rats by inhabiting the ROCK/NF-κB/C3 signaling pathway. Together, Rho kinase inhibitor Y27632 effectively promotes the functional recovery of SCI by shifting astrocyte phenotype and morphology. Furthermore, the pro-regeneration event is strongly associated with the ROCK/NF-κB/C3 signal pathway.

Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates

Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves

Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo

Y-39983 downregulates RhoA/Rho-associated kinase expression during its promotion of axonal regeneration.

The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar

Rho signaling pathway targeted to promote spinal cord repair

Enhanced Neurite Outgrowth of Human Model (NT2) Neurons by Small-Molecule Inhibitors of Rho/ROCK Signaling

RhoA as a target to promote neuronal survival and axon regeneration

Ca2+-Dependent Regulation of Rho GTPases Triggers Turning of Nerve Growth Cones

Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice

Strategies to neutralize RhoA/ROCK pathway after spinal cord injury

Pathways regulating modality-specific axonal regeneration in peripheral nerve

Doublecortin-Like Kinases Promote Neuronal Survival and Induce Growth Cone Reformation Via Distinct Mechanisms.

Rho Kinase Inhibitor Y27632 Improves Recovery after Spinal Cord Injury by Shifting Astrocyte Phenotype and Morphology Via the ROCK/NF-κB/C3 Pathway

Rho-associated Protein Kinase Modulates Neurite Extension by Regulating Microtubule Remodeling and Vinculin Distribution

Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway

Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord

Activation of Rho after spinal cord injury and the collapse of growth cone

Chronic neuronal activation increases dynamic microtubules to enhance functional axon regeneration after dorsal root crush injury

Disruption of Core Stress Granule Protein Aggregates Promotes CNS Axon Regeneration

Diltiazem Promotes Regenerative Axon Growth